Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Angiogenesis|November 6, 2012
Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cellsSabrina Cattaruzza, Ugur Ozerdem, Martin Denzel, et al.Current Eye Research|August 21, 2002
The effect of prinomastat (AG3340), a synthetic inhibitor of matrix metalloproteinases, on uveal melanoma rabbit modelUgur Ozerdem, Beata Mach-Hofacre, Nissi Varki, et al.Endocrine-Related Cancer|April 8, 2006
A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormoneEric Ueda, Ugur Ozerdem, Yen-Hao Chen, et al.Breast (Edinburgh, Scotland)|April 30, 2022
Macrophage density is an adverse prognosticator for ipsilateral recurrence in ductal carcinoma in situFarbod Darvishian, Yinxiang Wu, Ugur Ozerdem, et al.Experimental Biology and Medicine (Maywood, N.J.)|July 22, 2008
Ultrastructure of islet microcirculation, pericytes and the islet exocrine interface in the HIP rat model of diabetesMelvin R Hayden, Poorna R Karuparthi, Javad Habibi, et al.Annals of Surgical Oncology|June 27, 2019
Tumor-Infiltrating Lymphocytes in a Contemporary Cohort of Women with Ductal Carcinoma In Situ (DCIS)Farbod Darvishian, Ugur Ozerdem, Sylvia Adams, et al.Cancer Discovery|July 27, 2018
SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer ModelsCarmine Fedele, Hao Ran, Brian Diskin, et al.The Journal of Experimental Medicine|October 12, 2020
SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodelingCarmine Fedele, Shuai Li, Kai Wen Teng, et al.Nature Communications|May 20, 2026
Multi-modal AI for comprehensive breast cancer prognosticationJan Witowski, Ken G Zeng, Joseph Cappadona, et al.Pageof 4